Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 35, Issue 10, 2014, Pages 2423.e1-2423.e6

  Soong, Bing Wen ^a,b   Lin, Kon Ping ^a,b   Guo, Yuh Cherng ^c,d   Lin, Chou Ching K ^e,f   Tsai, Pei Chien ^a,b   Liao, Yi Chu ^a,b   Lu, Yi Chun ^a   Wang, Shuu Jiun ^a,b   Tsai, Ching Piao ^a,b   Lee, Yi Chung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

ALS; ATXN2; C9ORF72; FUS; HNRNPA1; OPTN; PFN1; SOD1; SQSTM1; TARDBP; UBQLN2; VCP

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; GENOMIC DNA; C9ORF72 PROTEIN, HUMAN; DNA BINDING PROTEIN; NERVE PROTEIN; OPTN PROTEIN, HUMAN; PROTEIN; PROTEIN TDP-43; REPETITIVE DNA; SCA2 PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR IIIA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATXN2 GENE; C9ORF72 GENE; CAG REPEAT; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FUS GENE; GENE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOME SIZE; HAN CHINESE; HNRNPA1 GENE; HNRNPA2B1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MUTATION RATE; MUTATIONAL ANALYSIS; OPEN READING FRAME; OPTN GENE; PFN1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOD1 GENE; SQSTM1 GENE; TAIWANESE; TARDBP GENE; UBQLN2 GENE; VCP GENE; ASIAN CONTINENTAL ANCESTRY GROUP; GENETICS; MIDDLE AGED; MUTATION; TAIWAN; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DNA REPEAT EXPANSION; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; PROTEINS; SUPEROXIDE DISMUTASE; TAIWAN; TRANSCRIPTION FACTOR TFIIIA; YOUNG ADULT;

EID: 84903815825     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.008     Document Type: Article

References (54)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. Amethod and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000, 1:293-299.
3. Brown J.A., Min J., Staropoli J.F., Collin E., Bi S., Feng X., Barone R., Cao Y., O'Malley L., Xin W., Mullen T.E., Sims K.B. SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph. Lateral Scler. 2012, 13:217-222.
4. Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., McLaughlin R.L., Iyer P.M., O'Brien C., Phukan J., Wynne B., Bokde A.L., Bradley D.G., Pender N., Al-Chalabi A., Hardiman O. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9ORF72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012, 11:232-240.
5. Chen Y., Huang R., Yang Y., Chen K., Song W., Pan P., Li J., Shang H.F. Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patient with amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32:1925.e1-1925.e5.
6. Chen Y., Zheng Z.Z., Huang R., Chen K., Song W., Zhao B., Chen X., Yang Y., Yuan L., Shang H.F. PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiol. Aging 2013, 34:1922.e1-1922.e5.
7. Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., Nicholson G.A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J.W., Fischbeck K.H., Timmerman V., Cornblath D.R., Chance P.F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 2004, 74:1128-1135.
8. Chiò A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., Sendtner M., Brunetti M., Ossola I., Calvo A., Pugliatti M., Sotgiu M.A., Murru M.R., Marrosu M.G., Marrosu F., Marinou K., Mandrioli J., Sola P., Caponnetto C., Mancardi G., Mandich P., La Bella V., Spataro R., Conte A., Monsurro M.R., Tedeschi G., Pisano F., Bartolomei I., Salvi F., Lauria Pinter G., Simone I., Logroscino G., Gambardella A., Quattrone A., Lunetta C., Volanti P., Zollino M., Penco S., Battistini S., Renton A.E., Majounie E., Abramzon Y., Conforti F.L., Giannini F., Corbo M., Sabatelli M. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012, 135:784-793.
9. Chiò A., Calvo A., Mazzini L., Cantello R., Mora G., Moglia C., Corrado L., D'Alfonso S., Majounie E., Renton A., Pisano F., Ossola I., Brunetti M., Traynor B.J., Restagno G., PARALS Extensive genetics of ALS: a population-based study in Italy. Neurology 2012, 79:1983-1989.
10. Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S., Figlewicz D., Brown R.H., Meisler M.H. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am. J. Hum. Genet. 2009, 84:85-88.
11. Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., Baxter L., Forster G., Fox M., Bury J., Mok K., McDermott C.J., Traynor B.J., Kirby J., Wharton S.B., Ince P.G., Hardy J., Shaw P.J. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012, 135:751-764.
12. Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., Brown R.H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 1997, 41:210-221.
13. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
14. Del Bo R., Tiloca C., Pensato V., Corrado L., Ratti A., Ticozzi N., Corti S., Castelloti B., Mazzini L., Soraru G., Cereda C., D'Alfonso S., Gellera C., Comi G.P., Silani V. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J.Neurol. Neurosurg. Psychiatry 2011, 82:1239-1243. SLAGEN Consortium.
15. Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S., Bigio E.H., Brooks B.R., Ajroud K., Sufit R.L., Haines J.L., Mugnaini E., Pericak-Vance M.A., Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011, 477:211-215.
16. Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., Gruber P.J., Rub U., Auburger G., Trojanowski J.Q., Lee V.M., Van Deerlin V.M., Bonini N.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010, 466:1069-1075.
17. Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., Donkervoort S., Ajroud-Driss S., Sufit R.L., Heller S.L., Deng H.X., Siddique T. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011, 68:1440-1446.
18. Gellera C., Ticozzi N., Pensato V., Nanetti L., Castucci A., Castellotti B., Lauria G., Taroni F., Silani V., Mariotti C. ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling. Neurobiol. Aging 2012, 33:1847.e15-1847.e21.
19. Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., Engelborghs S., Sieben A., De Jonghe P., Vandenberghe R., Santens P., De Bleecker J., Maes G., Baumer V., Dillen L., Joris G., Cuijt I., Corsmit E., Elinck E., Van Dongen J., Vermeulen S., Van den Broeck M., Vaerenberg C., Mattheijssens M., Peeters K., Robberecht W., Cras P., Martin J.J., De Deyn P.P., Cruts M., Van Broeckhoven C. AC9ORF72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012, 11:54-65.
20. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 2006, 38:411-413.
21. Iida A., Hosono N., Sano M., Kamei T., Oshima S., Tokuda T., Kubo M., Nakamura Y., Ikegawa S. Optineurin mutations in Japanese amyotrophic lateral sclerosis. J.Neurol. Neurosurg. Psychiatry 2012, 83:233-235.
22. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chio A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
23. Johnson L., Miller J.W., Gkazi A.Z., Vance C., Topp S.D., Newhouse S.J., Al-Chalabi A., Smith B.N., Shaw C.E. Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients. Neurobiol. Aging 2012, 33:2948.e15-2948.e17.
24. Kalmar B., Lu C.H., Greensmith L. The role of heat shock proteins in amyotrophic lateral sclerosis: the therapeutic potential of Arimoclomol. Pharmacol. Ther. 2014, 141:40-54.
25. Kenna K.P., McLaughlin R.L., Byrne S., Elamin M., Heverin M., Kenny E.M., Cormican P., Morris D.W., Donaghy C.G., Bradley D.G., Hardiman O. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J.Med. Genet. 2013, 50:776-783.
26. Kim H.J., Kim N.C., Wang Y.D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., Kanagaraj A.P., Carter R., Boylan K.B., Wojtas A.M., Rademakers R., Pinkus J.L., Greenberg S.A., Trojanowski J.Q., Traynor B.J., Smith B.N., Topp S., Gkazi A.S., Miller J., Shaw C.E., Kottlors M., Kirschner J., Pestronk A., Li Y.R., Ford A.F., Gitler A.D., Benatar M., King O.D., Kimonis V.E., Ross E.D., Weihl C.C., Shorter J., Taylor J.P. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013, 495:467-473.
27. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4:1073-1081.
28. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
29. Kwon M.J., Baek W., Ki C.S., Kim H.Y., Koh S.H., Kim J.W., Kim S.H. Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS. Neurobiol. Aging 2012, 33:1017.e17-1017.e23.
30. Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 2013, 34:812-826.
31. Liu X., Lu M., Tang L., Zhang N., Chui D., Fan D. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis. Neurobiol. Aging 2013, 34:2236.e5-2236.e8.
32. Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., Chio A., Restagno G., Nicolaou N., Simon-Sanchez J., van Swieten J.C., Abramzon Y., Johnson J.O., Sendtner M., Pamphlett R., Orrell R.W., Mead S., Sidle K.C., Houlden H., Rohrer J.D., Morrison K.E., Pall H., Talbot K., Ansorge O., Hernandez D.G., Arepalli S., Sabatelli M., Mora G., Corbo M., Giannini F., Calvo A., Englund E., Borghero G., Floris G.L., Remes A.M., Laaksovirta H., McCluskey L., Trojanowski J.Q., Van Deerlin V.M., Schellenberg G.D., Nalls M.A., Drory V.E., Lu C.S., Yeh T.H., Ishiura H., Takahashi Y., Tsuji S., Le Ber I., Brice A., Drepper C., Williams N., Kirby J., Shaw P., Hardy J., Tienari P.J., Heutink P., Morris H.R., Pickering-Brown S., Traynor B.J. Frequency of the C9ORF72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012, 11:323-330.
33. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
34. Millecamps S., Salachas F., Cazeneuve C., Gordon P., Bricka B., Camuzat A., Guillot-Noël L., Russaouen O., Bruneteau G., Pradat P.F., Le Forestier N., Vandenberghe N., Danel-Brunaud V., Guy N., Thauvin-Robinet C., Lacomblez L., Couratier P., Hannequin D., Seilhean D., Le Ber I., Corcia P., Camu W., Brice A., Rouleau G., LeGuern E., Meininger V. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J.Med. Genet. 2010, 47:554-560.
35. Miller T.M., Pestronk A., David W., Rothstein J., Simpson E., Appel S.H., Andres P.L., Mahoney K., Allred P., Alexander K., Ostrow L.W., Schoenfeld D., Macklin E.A., Norris D.A., Manousakis G., Crisp M., Smith R., Bennett C.F., Bishop K.M., Cudkowicz M.E. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013, 12:435-442.
36. Mitchell J., Paul P., Chen H.J., Morris A., Payling M., Falchi M., Habgood J., Panoutsou S., Winkler S., Tisato V., Hajitou A., Smith B., Vance C., Shaw C., Mazarakis N.D., de Belleroche J. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7556-7561.
37. Murray M.E., DeJesus-Hernandez M., Rutherford N.J., Baker M., Duara R., Graff-Radford N.R., Wszolek Z.K., Ferman T.J., Josephs K.A., Boylan K.B., Rademakers R., Dickson D.W. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 2011, 122:673-690.
38. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., Zatz M. Amutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75:822-831.
39. Ogaki K., Li Y., Atsuta N., Tomiyama H., Funayama M., Watanabe H., Nakamura R., Yoshino H., Yato S., Tamura A., Naito Y., Taniguchi A., Fujita K., Izumi Y., Kaji R., Hattori N., Sobue G. Analysis of C9ORF72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:2527.e11-2527.e16. Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS).
40. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
41. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364:362.
42. Sabatelli M., Conforti F.L., Zollino M., Mora G., Monsurro M.R., Volanti P., Marinou K., Salvi F., Corbo M., Giannini F., Battistini S., Penco S., Lunetta C., Quattrone A., Gambardella A., Logroscino G., Simone I., Bartolomei I., Pisano F., Tedeschi G., Conte A., Spataro R., La Bella V., Caponnetto C., Mancardi G., Mandich P., Sola P., Mandrioli J., Renton A.E., Majounie E., Abramzon Y., Marrosu F., Marrosu M.G., Murru M.R., Sotgiu M.A., Pugliatti M., Rodolico C., Moglia C., Calvo A., Ossola I., Brunetti M., Traynor B.J., Borghero G., Restagno G., Chio A. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol. Aging 2012, 33:1848.e15-1848.e20.
43. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
44. Sreedharan J., Brown R.H. Amyotrophic lateral sclerosis: problems and prospects. Ann. Neurol. 2013, 74:309-316.
45. Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., Belzil V.V., Dion P.A., Higasa K., Doi K., Ishiura H., Mitsui J., Date H., Ahsan B., Matsukawa T., Ichikawa Y., Moritoyo T., Ikoma M., Hashimoto T., Kimura F., Murayama S., Onodera O., Nishizawa M., Yoshida M., Atsuta N., Sobue G., JaCALS, Fifita J.A., Williams K.L., Blair I.P., Nicholson G.A., Gonzalez-Perez P., Brown R.H., Nomoto M., Elenius K., Rouleau G.A., Fujiyama A., Morishita S., Goto J., Tsuji S. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. 2013, 93:900-905.
46. Tsai C.P., Soong B.W., Lin K.P., Tu P.H., Lin J.L., Lee Y.C. FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. Neurobiol. Aging 2011, 32:553.e513-553.e521.
47. Tsai C.P., Soong B.W., Tu P.H., Lin K.P., Fuh J.L., Tsai P.C., Lu Y.C., Lee I.H., Lee Y.C. Ahexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol. Aging 2012, 33:2232.e11-2232.e18.
48. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
49. Van Damme P., Veldink J.H., van Blitterswijk M., Corveleyn A., van Vught P.W., Thijs V., Dubois B., Matthijs G., van den Berg L.H., Robberecht W. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 2011, 76:2066-2072.
50. Wu C.H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., Kost J.E., Gonzalez-Perez P., Fox A.D., Adams J., Taroni F., Tiloca C., Leclerc A.L., Chafe S.C., Mangroo D., Moore M.J., Zitzewitz J.A., Xu Z.S., van den Berg L.H., Glass J.D., Siciliano G., Cirulli E.T., Goldstein D.B., Salachas F., Meininger V., Rossoll W., Ratti A., Gellera C., Bosco D.A., Bassell G.J., Silani V., Drory V.E., Brown R.H., Landers J.E. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 2012, 488:499-503.
51. Zlotogora J. High frequencies of human genetic diseases: founder effect with genetic drift or selection?. Am. J. Med. Genet. 1994, 49:10-13.
52. Zou Z.Y., Li X.G., Liu M.S., Cui L.Y. Screening for C9ORF72 repeat expansions in Chinese amyotrophic lateral sclerosis patients. Neurobiol. Aging 2013, 34:1710.e5-1710.e6.
53. Zou Z.Y., Liu M.S., Li X.G., Cui L.Y. Screening of VCP mutations in Chinese amyotrophic lateral sclerosis patients. Neurobiol. Aging 2013, 34:1519.e3-1519.e4.
54. Zou Z.Y., Sun Q., Liu M.S., Li X.G., Cui L.Y. Mutations in the profilin 1 gene are not common in amyotrophic lateral sclerosis of Chinese origin. Neurobiol. Aging 2013, 34:1713.e5-1713.e6.